Oddo BHF - Morning CrÃ©dit 14/06/2017

Report

Oddo BHF

Carole Braudeau

Morning CrÃ©dit 14/06/2017

Astaldi compte Ã©mettre une obligation convertible 2024 de 140 m EUR maximum et lance une offre dâ€™achat sur lâ€™obligation convertible 2019.CMA CGM va racheter Mercosul Line Ã Maersk (Baa2/BBB) pour un prix non communiquÃ©Le patron de la direction de la concurrence allemande exclut toute aide publique pour Air Berlin (Die Welt)>

14/06/2017 17 FR

Provider

Oddo BHF

Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

See profile

Analysts

Carole Braudeau

Other Reports from Oddo BHF

Carole Braudeau

Carole Braudeau

Morning Crédit 26/08/2025

1h / 21m 1h / 21m 1 FR

Carole Braudeau

Carole Braudeau

Credit Morning 08/26/2025

1h / 21m 1h / 21m 1 EN

Oliver Metzger ... (+2)

Oliver Metzger
Stephan Wulf

Dermapharm Holding SE : H1 figures confirm prel. results– Strong performance of Branded Pharma

1h / 21m 1h / 21m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Morning CrÃ©dit 14/06/2017

Morning Crédit 26/08/2025

Credit Morning 08/26/2025

Dermapharm Holding SE : H1 figures confirm prel. results– Strong performance of Branded Pharma

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe